Latest / Going Public With Ross Mandell
Eli Lilly Stock: Why the Weight-Loss Boom Is Just Beginning
Join Ross’s Patreon Community for exclusive content and LIVE events
https://www.patreon.com/cw/TheRealRossMandell?utm_campaign=creatorshare_creator
Is Eli Lilly stock still in the early stages of the weight-loss boom? In this episode of Going Public with Ross Mandell, Ross breaks down his bullish outlook on LLY stock and explains why Mounjaro and Zepbound could be just the beginning. Explore how diabetes treatments, obesity drugs, and the growing GLP-1 market fit into his investment thesis.
The discussion covers oral weight-loss treatments such as orforglipron, retatrutide’s clinical…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.